Quince Therapeutics (QNCX) Institutional Ownership $1.40 -0.05 (-3.45%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.41 +0.01 (+1.00%) As of 02/21/2025 05:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Quince Therapeutics (NASDAQ:QNCX)CurrentInstitutional OwnershipPercentage30.75%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$678.16KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$27.15K Get QNCX Insider Trade Alerts Want to know when executives and insiders are buying or selling Quince Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data QNCX Institutional Buying and Selling by Quarter Quince Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Two Sigma Investments LP30,341$57K0.0%N/A0.069% 2/17/2025 Shay Capital LLC276,799$518K0.1%+60.8%0.629% 2/14/2025 Northern Trust Corp50,524$94K0.0%+48.5%0.115% 2/12/2025 Geode Capital Management LLC375,932$703K0.0%+10.9%0.854% 2/11/2025 Virtu Financial LLC29,204$55K0.0%N/A0.066% 2/5/2025 Anfield Capital Management LLC26,656$50K0.0%N/A0.061% 1/24/2025 Scharf Investments LLC91,061$170K0.0%N/A0.207% 11/16/2024 Geode Capital Management LLC339,125$263K0.0%+24.2%0.784% 8/9/2024 Renaissance Technologies LLC483,902$363K0.0%-7.0%1.120% 1/12/2024 Scharf Investments LLC91,061$96K0.0%N/A0.212% 7/31/2023 Intellectus Partners LLC53,527$81K0.0%N/A0.148% 7/24/2023 BML Capital Management LLC1,411,839$2.13M1.9%N/A3.892% 5/11/2023 EPIQ Capital Group LLC958,469$1.50M0.8%-9.3%2.642% 4/20/2023 Hennion & Walsh Asset Management Inc.31,061$48K0.0%N/A0.086% (Data available from 1/1/2016 forward) QNCX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of QNCX shares? During the previous two years, 12 institutional investors and hedge funds held shares of Quince Therapeutics. The most heavily invested institutionals were BML Capital Management LLC ($2.13M), EPIQ Capital Group LLC ($1.50M), Geode Capital Management LLC ($703K), Shay Capital LLC ($518K), Renaissance Technologies LLC ($363K), Scharf Investments LLC ($170K), and Northern Trust Corp ($94K).Learn more on QNCX's institutional investors. What percentage of Quince Therapeutics stock is owned by institutional investors? 30.75% of Quince Therapeutics stock is owned by institutional investors. Learn more on QNCX's institutional investor holdings. Which institutional investors have been buying Quince Therapeutics stock? Of the 10 institutional investors that purchased Quince Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BML Capital Management LLC ($1.41M), Scharf Investments LLC ($182.12K), Shay Capital LLC ($104.62K), Geode Capital Management LLC ($102.98K), Intellectus Partners LLC ($53.53K), Hennion & Walsh Asset Management Inc. ($31.06K), and Two Sigma Investments LP ($30.34K). How much institutional buying is happening at Quince Therapeutics? Institutional investors have bought a total of 1,988,844 shares in the last 24 months. This purchase volume represents approximately $3.03M in transactions. Which Quince Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Quince Therapeutics stock in the last 24 months: EPIQ Capital Group LLC ($97.72K), and Renaissance Technologies LLC ($36.20K). How much institutional selling is happening at Quince Therapeutics? Institutional investors have sold a total of 133,920 shares in the last 24 months. This volume of shares sold represents approximately $179.59K in transactions. Related Companies Alumis Major Shareholders LifeVantage Major Shareholders Voyager Therapeutics Major Shareholders Design Therapeutics Major Shareholders 4D Molecular Therapeutics Major Shareholders Lifecore Biomedical Major Shareholders C4 Therapeutics Major Shareholders Cardiff Oncology Major Shareholders Acelyrin Major Shareholders Larimar Therapeutics Major Shareholders This page (NASDAQ:QNCX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quince Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quince Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
